P.M. Steijlen

539 total citations
18 papers, 304 citations indexed

About

P.M. Steijlen is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, P.M. Steijlen has authored 18 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in P.M. Steijlen's work include Genetic and rare skin diseases. (4 papers), Vascular Malformations and Hemangiomas (3 papers) and Cancer and Skin Lesions (3 papers). P.M. Steijlen is often cited by papers focused on Genetic and rare skin diseases. (4 papers), Vascular Malformations and Hemangiomas (3 papers) and Cancer and Skin Lesions (3 papers). P.M. Steijlen collaborates with scholars based in Netherlands, Switzerland and United Kingdom. P.M. Steijlen's co-authors include Maurice A. M. Van Steensel, W. Bergman, D. J. Ruiter, Jo Hermans, E. Scheffer, T Strachan, Michel van Geel, Eugene Healy, Huckaby Lewis and G Nagy and has published in prestigious journals such as Human Molecular Genetics, British Journal of Dermatology and Histopathology.

In The Last Decade

P.M. Steijlen

17 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.M. Steijlen Netherlands 10 143 127 100 75 68 18 304
Sebastian Singer Germany 5 202 1.4× 133 1.0× 155 1.6× 41 0.5× 63 0.9× 7 325
Mark E. Hutchin United States 6 133 0.9× 289 2.3× 88 0.9× 89 1.2× 21 0.3× 7 465
Eva Herschberger Germany 4 222 1.6× 139 1.1× 134 1.3× 47 0.6× 57 0.8× 4 305
Kimberly Nicholson United States 8 64 0.4× 63 0.5× 102 1.0× 72 1.0× 26 0.4× 10 308
Jennifer Ferris United States 6 90 0.6× 262 2.1× 63 0.6× 134 1.8× 26 0.4× 8 425
Richard G. Del Mastro United Kingdom 6 83 0.6× 303 2.4× 120 1.2× 38 0.5× 16 0.2× 8 379
Agne Liedén Sweden 13 67 0.5× 88 0.7× 210 2.1× 28 0.4× 27 0.4× 21 445
R Happle Germany 9 93 0.7× 79 0.6× 139 1.4× 11 0.1× 72 1.1× 33 318
Cinzia Mazzanti Italy 9 193 1.3× 189 1.5× 199 2.0× 33 0.4× 75 1.1× 13 403
Päivi M. Hägg Finland 10 67 0.5× 120 0.9× 76 0.8× 13 0.2× 56 0.8× 13 274

Countries citing papers authored by P.M. Steijlen

Since Specialization
Citations

This map shows the geographic impact of P.M. Steijlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. Steijlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. Steijlen more than expected).

Fields of papers citing papers by P.M. Steijlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M. Steijlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. Steijlen. The network helps show where P.M. Steijlen may publish in the future.

Co-authorship network of co-authors of P.M. Steijlen

This figure shows the co-authorship network connecting the top 25 collaborators of P.M. Steijlen. A scholar is included among the top collaborators of P.M. Steijlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M. Steijlen. P.M. Steijlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Roozeboom, Marieke H., Patricia J. Nelemans, Klara Mosterd, et al.. (2014). Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial. British Journal of Dermatology. 172(3). 739–745. 28 indexed citations
2.
Nagtzaam, Ivo F., Michel van Geel, Ann Driessen, P.M. Steijlen, & Maurice A. M. Van Steensel. (2010). Bile duct paucity is part of the neonatal ichthyosis-sclerosing cholangitis phenotype. British Journal of Dermatology. 163(1). 205–207. 21 indexed citations
3.
Damstra, Robert J., et al.. (2009). Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature. European Journal of Cancer Care. 19(5). 669–675. 10 indexed citations
4.
Steensel, Maurice A. M. Van, Véronique Winnepenninckx, Ivo F. Nagtzaam, et al.. (2008). A case of Lelis syndrome with hystrix‐like ichthyosis. American Journal of Medical Genetics Part A. 146A(16). 2155–2158.
5.
Steensel, Maurice A. M. Van, et al.. (2007). Lymphedema, cardiac septal defects, and characteristic facies: Possible new case of Irons–Bianchi syndrome. American Journal of Medical Genetics Part A. 143A(20). 2448–2451. 3 indexed citations
6.
Steensel, Maurice A. M. Van, Michel van Geel, & P.M. Steijlen. (2006). Further delineation of the hypotrichosis-deafness syndrome.. PubMed. 15(6). 437–8. 5 indexed citations
7.
Steensel, Maurice A. M. Van, Maaike Vreeburg, P.M. Steijlen, & Christine de Die‐Smulders. (2005). Myhre syndrome in a female with previously undescribed symptoms: Further delineation of the phenotype. American Journal of Medical Genetics Part A. 139A(2). 127–130. 16 indexed citations
8.
Glade, Conrad P., Maurice A. M. Van Steensel, & P.M. Steijlen. (2001). Hypotrichosis, lymphedema of the legs and acral telangiectasias--new syndrome?. PubMed. 11(6). 515–7. 15 indexed citations
9.
Steijlen, P.M., et al.. (2000). CO 2 laser treatment of benign juvenile acanthosis nigricans. European Journal of Plastic Surgery. 23(4). 238–240. 4 indexed citations
10.
Ruiz‐Pérez, Víctor L., Eugene Healy, C. Todd, et al.. (1999). ATP2A2 Mutations in Darier's Disease: Variant Cutaneous Phenotypes Are Associated with Missense Mutations, But Neuropsychiatry Features Are Independent of Mutation Class. Human Molecular Genetics. 8(9). 1621–1630. 104 indexed citations
11.
Dongen, P.W.J. van, et al.. (1997). Ehlers-Danlos syndroom IV: variatie in fenotypen. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 141(6). 296–298. 3 indexed citations
12.
Boetes, C., A.P.M. Boll, Paul N.M.A. Rieu, et al.. (1997). Het congenitale angiodysplasiesyndroom van het type Klippel-Trenaunay; medische en psychologische aspecten. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 141. 650–651. 1 indexed citations
13.
Lucker, G.P.H., P.C.M. van de Kerkhof, J.R.M. Cruysberg, D.J. der Kinderen, & P.M. Steijlen. (1995). Topical Treatment of Sjögren-Larsson Syndrome with Calcipotriol. Dermatology. 190(4). 292–294. 19 indexed citations
14.
Arnold, W.P., Matthias A.W. Merkx, & P.M. Steijlen. (1995). Variant of odontoonychodermal dysplasia?. American Journal of Medical Genetics. 59(2). 242–244. 9 indexed citations
15.
Kerkhof, P.C.M. van de & P.M. Steijlen. (1995). IgA Deficiency and Psoriasis: Relevance of IgA in the Pathogenesis of Psoriasis. Dermatology. 191(1). 46–48. 5 indexed citations
16.
Steijlen, P.M., et al.. (1990). [Pigmented vascular phakomatosis].. PubMed. 43(1). 34–5. 2 indexed citations
17.
Happle, Rudolf, et al.. (1990). [CHILD syndrome in a mother and daughter].. PubMed. 41(2). 105–8. 18 indexed citations
18.
Steijlen, P.M., et al.. (1988). The efficacy of histopathological criteria required for diagnosing dysplastic naevi. Histopathology. 12(3). 289–300. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026